Cargando…
P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429268/ http://dx.doi.org/10.1097/01.HS9.0000846896.29524.36 |
| _version_ | 1784779387490533376 |
|---|---|
| author | Kirito, K. Edahiro, Y. Ohishi, K. Gotoh, A. Takenaka, K. Shibayama, H. Shimizu, T. Usuki, K. Shimoda, K. Ito, M. VanWart, S. A. Zagrijtschuk, O. Qin, A. Kawase, H. Miyachi, N. Sato, T. Komatsu, N. |
| author_facet | Kirito, K. Edahiro, Y. Ohishi, K. Gotoh, A. Takenaka, K. Shibayama, H. Shimizu, T. Usuki, K. Shimoda, K. Ito, M. VanWart, S. A. Zagrijtschuk, O. Qin, A. Kawase, H. Miyachi, N. Sato, T. Komatsu, N. |
| author_sort | Kirito, K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429268 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292682022-08-31 P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA Kirito, K. Edahiro, Y. Ohishi, K. Gotoh, A. Takenaka, K. Shibayama, H. Shimizu, T. Usuki, K. Shimoda, K. Ito, M. VanWart, S. A. Zagrijtschuk, O. Qin, A. Kawase, H. Miyachi, N. Sato, T. Komatsu, N. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429268/ http://dx.doi.org/10.1097/01.HS9.0000846896.29524.36 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kirito, K. Edahiro, Y. Ohishi, K. Gotoh, A. Takenaka, K. Shibayama, H. Shimizu, T. Usuki, K. Shimoda, K. Ito, M. VanWart, S. A. Zagrijtschuk, O. Qin, A. Kawase, H. Miyachi, N. Sato, T. Komatsu, N. P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA |
| title | P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA |
| title_full | P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA |
| title_fullStr | P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA |
| title_full_unstemmed | P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA |
| title_short | P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA |
| title_sort | p1007: phase 2, open-label, multicenter, single-arm study investigating the efficacy and safety of ropeginterferon alfa-2b in japanese patients with polycythemia vera |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429268/ http://dx.doi.org/10.1097/01.HS9.0000846896.29524.36 |
| work_keys_str_mv | AT kiritok p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT edahiroy p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT ohishik p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT gotoha p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT takenakak p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT shibayamah p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT shimizut p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT usukik p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT shimodak p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT itom p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT vanwartsa p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT zagrijtschuko p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT qina p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT kawaseh p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT miyachin p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT satot p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera AT komatsun p1007phase2openlabelmulticentersinglearmstudyinvestigatingtheefficacyandsafetyofropeginterferonalfa2binjapanesepatientswithpolycythemiavera |